Literature DB >> 18790462

Psychosocial determinants of intention to screen for Alzheimer's disease.

James E Galvin1, Qiang Fu, Joseph T Nguyen, Cristie Glasheen, Darcell P Scharff.   

Abstract

BACKGROUND: There is little information about how receptive older adults are to discuss memory problems with healthcare providers. Here we test the psychosocial factors explaining older adults' intention to undergo screening for Alzheimer disease (AD).
METHODS: A population-based, random-digit dialing strategy surveyed 1,039 older adults. The Behavioral Model of Health Services Use was used as a conceptual framework for a questionnaire testing constructs from several behavioral theories. Structural equation modeling assessed the relationship of latent variables to each construct with goodness-of-fit indices.
RESULTS: The study had an 82% response rate and 72% completer rate. The respondents' mean age was 62.7 +/- 10.2 years (range, 50 to 97 years). The sample was 67% women, 86% were white, and less than 40% had personal experience with AD. Respondents were nondemented (Short Blessed scores, 1.7 +/- 2.2). Predictors of intention to screen included perceived benefits (gamma = .35), knowledge of dementia (gamma = .26), self-efficacy (gamma = .23), preventive health behaviors (gamma = .17), and perceived susceptibility (gamma = .14). Knowledge was positively correlated with perceived benefits (phi = .29) and susceptibility (phi = .20). Preventive behaviors (phi = .20) were positively correlated with perceived benefits. Self-efficacy correlated positively with preventive behaviors (phi = .24) and perceived benefits (phi = .37) and negatively with perceived susceptibility (phi = -.11). Goodness-of-fit indices suggested a good fit of this model (root mean square error of approximation, .037; comparative fit index, 0.98; relative fit index; .96). DISCUSSION: Older adults who have knowledge of dementia and perceive benefit from diagnosis and treatment are more likely to exhibit willingness and confidence to be tested for cognitive problems. Individuals with high self-efficacy, perceived susceptibility, and positive preventive health behaviors are also more likely to exhibit intention. These constructs can now be used to develop interventions to evaluate cognitive health in the elderly.

Entities:  

Mesh:

Year:  2007        PMID: 18790462      PMCID: PMC2608720          DOI: 10.1016/j.jalz.2007.09.005

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  42 in total

1.  Factors influencing intentions to seek a cognitive status examination: a study based on the Health Belief Model.

Authors:  Perla Werner
Journal:  Int J Geriatr Psychiatry       Date:  2003-09       Impact factor: 3.485

Review 2.  Validation of screening procedures.

Authors:  A L Cochrane; W W Holland
Journal:  Br Med Bull       Date:  1971-01       Impact factor: 4.291

3.  Belief importance and the theory of planned behaviour: comparing modal and ranked modal beliefs in predicting attendance at breast screening.

Authors:  Liz Steadman; D R Rutter
Journal:  Br J Health Psychol       Date:  2004-11

4.  Acceptance of dementia screening in continuous care retirement communities: a mailed survey.

Authors:  Malaz Boustani; Lea Watson; Bridget Fultz; Anthony J Perkins; Richard Druckenbrod
Journal:  Int J Geriatr Psychiatry       Date:  2003-09       Impact factor: 3.485

5.  A prospective, controlled assessment of factors influencing acceptance of screening colonoscopy.

Authors:  Gavin C Harewood; Maurits J Wiersema; L Joseph Melton
Journal:  Am J Gastroenterol       Date:  2002-12       Impact factor: 10.864

6.  Health promotion by social cognitive means.

Authors:  Albert Bandura
Journal:  Health Educ Behav       Date:  2004-04

Review 7.  A framework for improving the quality of cancer care: the case of breast and cervical cancer screening.

Authors:  Jane G Zapka; Stephen H Taplin; Leif I Solberg; M Michele Manos
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-01       Impact factor: 4.254

8.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.

Authors:  William E Klunk; Henry Engler; Agneta Nordberg; Yanming Wang; Gunnar Blomqvist; Daniel P Holt; Mats Bergström; Irina Savitcheva; Guo-feng Huang; Sergio Estrada; Birgitta Ausén; Manik L Debnath; Julien Barletta; Julie C Price; Johan Sandell; Brian J Lopresti; Anders Wall; Pernilla Koivisto; Gunnar Antoni; Chester A Mathis; Bengt Långström
Journal:  Ann Neurol       Date:  2004-03       Impact factor: 10.422

9.  Intentions of first-degree relatives of patients with Alzheimer's disease to seek a cognitive status examination.

Authors:  Perla Werner; Jeremia Heinik
Journal:  Int J Geriatr Psychiatry       Date:  2004-05       Impact factor: 3.485

10.  Knowledge about symptoms of Alzheimer's disease: correlates and relationship to help-seeking behavior.

Authors:  Perla Werner
Journal:  Int J Geriatr Psychiatry       Date:  2003-11       Impact factor: 3.485

View more
  14 in total

1.  Clinical implications of APOE genotyping for late-onset Alzheimer's disease (LOAD) risk estimation: a review of the literature.

Authors:  Victoria S Marshe; Ilona Gorbovskaya; Sarah Kanji; Maxine Kish; Daniel J Müller
Journal:  J Neural Transm (Vienna)       Date:  2018-10-31       Impact factor: 3.575

2.  Comparison of 2 informant questionnaire screening tools for dementia and mild cognitive impairment: AD8 and IQCODE.

Authors:  Mehrdad Razavi; Magdalena I Tolea; Jennifer Margrett; Peter Martin; Andrew Oakland; David W Tscholl; Sarah Ghods; Mazdak Mina; James E Galvin
Journal:  Alzheimer Dis Assoc Disord       Date:  2014 Apr-Jun       Impact factor: 2.703

3.  Factors Affecting Intention to Undergo Dementia Screening.

Authors:  Shinya Takeda; Maki Ota; Toshiatsu Taniguchi
Journal:  Yonago Acta Med       Date:  2017-03-09       Impact factor: 1.641

4.  Caregiver and noncaregiver attitudes toward dementia screening.

Authors:  Malaz A Boustani; Michael D Justiss; Amie Frame; Mary G Austrom; Anthony J Perkins; Xueya Cai; Greg A Sachs; Alexia M Torke; Patrick Monahan; Hugh C Hendrie
Journal:  J Am Geriatr Soc       Date:  2011-03-25       Impact factor: 5.562

5.  Relationship of dementia screening tests with biomarkers of Alzheimer's disease.

Authors:  James E Galvin; Anne M Fagan; David M Holtzman; Mark A Mintun; John C Morris
Journal:  Brain       Date:  2010-09-07       Impact factor: 13.501

6.  The primary care physician and Alzheimer's disease: an international position paper.

Authors:  H Villars; S Oustric; S Andrieu; J P Baeyens; R Bernabei; H Brodaty; K Brummel-Smith; C Celafu; N Chappell; J Fitten; G Frisoni; L Froelich; O Guerin; G Gold; I Holmerova; S Iliffe; A Lukas; R Melis; J E Morley; H Nies; F Nourhashemi; J Petermans; J Ribera Casado; L Rubenstein; A Salva; C Sieber; A Sinclair; R Schindler; E Stephan; R Y Wong; B Vellas
Journal:  J Nutr Health Aging       Date:  2010-02       Impact factor: 4.075

Review 7.  Attitudes and preferences towards screening for dementia: a systematic review of the literature.

Authors:  Steven Martin; Sarah Kelly; Ayesha Khan; Sarah Cullum; Tom Dening; Greta Rait; Chris Fox; Cornelius Katona; Theodore Cosco; Carol Brayne; Louise Lafortune
Journal:  BMC Geriatr       Date:  2015-06-16       Impact factor: 3.921

8.  What older adults do with the results of dementia screening programs.

Authors:  James E Galvin; Magdalena I Tolea; Stephanie Chrisphonte
Journal:  PLoS One       Date:  2020-07-01       Impact factor: 3.240

9.  Attitudes of the German general population toward early diagnosis of dementia--results of a representative telephone survey.

Authors:  Tobias Luck; Melanie Luppa; Jennifer Sieber; Georg Schomerus; Perla Werner; Hans-Helmut König; Steffi G Riedel-Heller
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240

10.  Intention to Screen for Alzheimer's Disease by Residential Locale.

Authors:  Lilah M Besser; Willa D Brenowitz; Juyoung Park; Magdalena I Tolea; James E Galvin
Journal:  Int J Environ Res Public Health       Date:  2020-03-27       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.